01600nas a2200349   4500000000100000008004100001260001300042653002600055653002300081653001900104653001600123653002900139653001600168653003800184653002700222653001900249653001100268653001200279653001200291653002900303653002400332653002600356653001300382653001700395100001600412700001800428245011200446300001100558490000800569520065900577022001401236       1974                            d  c1974 Dec10aAntibodies, Bacterial10aAntibody Formation10aChagas disease10aCoombs Test10aFalse Positive Reactions10aGlycolipids10aHemagglutination Inhibition Tests10aHemagglutination Tests10aHistoplasmosis10aHumans10aleprosy10aMalaria10aMycobacterium Infections10aMycobacterium bovis10aMycoplasma Infections10aSyphilis10aTuberculosis1 aReggiardo Z1 aMiddlebrook G00aSerologically active glycolipid families from Mycobacterium bovis BCG. II. Serologic studies on human sera.  a477-860 v1003 a<p>Serological tests with serologically active glycolipids from Mycobacterium bovis BCG were investigated for their possible use in the diagonis of mycobacterioses. The results were positive with 95 percent of sera from patients with far advanced and moderately advanced tuberculosis, 80 percent of sera from patients with newly diagnosed tuberculosis and 75 percent of patients with atypical mycobacterial diseases. "False" positive serologic reactions were obtained from 4 percent or less. Furthermore, 39 percent of sera from recent tuberculin converters were positive compared with only 9 percent of sera from unselected PPD positive individuals.</p>  a0002-9262